New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – ABEONA THERAPEUTICS INC. (0000318306) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Filed: 2017-01-27 AccNo: 0001144204-17-004313 Size: 15 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Filing Date: 2017-01-27T16:16:56-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/318306/000114420417004313/0001144204-17-004313-index.htm